Sudeep Maurya

  • PhD, Institute of Microbial Technology, 2013 - 2018
  • Master of Science, Devi Ahilya Vishwavidyalaya, 2008 - 2010

  • Leonard-Murali, S., Bhaskarla, C., Yadav, G.S., Maurya, S.K., Galiveti, C.R., Tobin, J.A., Kann, R.J., Ashwat, E., Murphy, P.S., Chakka, A.B., Soman, V., Cantalupo, P.G., Zhuo, X., Vyas, G., Kozak, D.L., Kelly, L.M., Smith, E., Chandran, U.R., Hsu, Y.M.S., & Kammula, U.S. (2024). Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility. Nat Commun, 15(1), 2863.Springer Nature. doi: 10.1038/s41467-024-46906-4.
  • Kumar Das, D., Zafar, M.A., Nanda, S., Singh, S., Lamba, T., Bashir, H., Singh, P., Maurya, S.K., Nadeem, S., Sehrawat, S., Bhalla, V., & Agrewala, J.N. (2022). Targeting dendritic cells with TLR-2 ligand-coated nanoparticles loaded with Mycobacterium tuberculosis epitope induce antituberculosis immunity. J Biol Chem, 298(12), 102596.Elsevier. doi: 10.1016/j.jbc.2022.102596.
  • Singh, S., Maurya, S.K., Aqdas, M., Bashir, H., Arora, A., Bhalla, V., & Agrewala, J.N. (2022). Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system. Cell Mol Life Sci, 79(11), 567.Springer Nature. doi: 10.1007/s00018-022-04596-5.
  • Aqdas, M., Maurya, S.K., Pahari, S., Singh, S., Khan, N., Sethi, K., Kaur, G., & Agrewala, J.N. (2021). Immunotherapeutic Role of NOD-2 and TLR-4 Signaling as an Adjunct to Antituberculosis Chemotherapy. ACS Infect Dis, 7(11), 2999-3008.American Chemical Society (ACS). doi: 10.1021/acsinfecdis.1c00136.
  • Aqdas, M., Singh, S., Amir, M., Maurya, S.K., Pahari, S., & Agrewala, J.N. (2021). Cumulative Signaling Through NOD-2 and TLR-4 Eliminates the Mycobacterium Tuberculosis Concealed Inside the Mesenchymal Stem Cells. Front Cell Infect Microbiol, 11, 669168.Frontiers. doi: 10.3389/fcimb.2021.669168.
  • Maurya, S.K., Aqdas, M., Das, D.K., Singh, S., Nadeem, S., Kaur, G., & Agrewala, J.N. (2020). A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis. BMC Infect Dis, 20(1), 677.Springer Nature. doi: 10.1186/s12879-020-05372-1.
  • Nadeem, S., Maurya, S.K., Das, D.K., Khan, N., & Agrewala, J.N. (2020). Gut Dysbiosis Thwarts the Efficacy of Vaccine Against Mycobacterium tuberculosis. Front Immunol, 11, 726.Frontiers. doi: 10.3389/fimmu.2020.00726.
  • Kaur, G., Chander, A.M.Kaur, G., Maurya, S.K., Nadeem, S., Kochhar, R., Bhadada, S.K., Agrewala, J.N., & Mayilraj, S. (2019). A genomic analysis of Mycobacterium immunogenum strain CD11_6 and its potential role in the activation of T cells against Mycobacterium tuberculosis. BMC Microbiol, 19(1), 64.Springer Nature. doi: 10.1186/s12866-019-1421-y.
  • Rai, P.K., Chodisetti, S.B., Maurya, S.K., Nadeem, S., Zeng, W., Janmeja, A.K., Jackson, D.C., & Agrewala, J.N. (2018). A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis. J Transl Med, 16(1), 279.Springer Nature. doi: 10.1186/s12967-018-1653-x.
  • Kujur, W., Gurram, R.K., Maurya, S.K., Nadeem, S., Chodisetti, S.B., Khan, N., & Agrewala, J.N. (2017). Caerulomycin A suppresses the differentiation of naïve T cells and alleviates the symptoms of experimental autoimmune encephalomyelitis. Autoimmunity, 50(5), 317-328.Taylor & Francis. doi: 10.1080/08916934.2017.1332185.
  • Rai, P.K., Chodisetti, S.B., Zeng, W., Nadeem, S., Maurya, S.K., Pahari, S., Janmeja, A.K., Jackson, D.C., & Agrewala, J.N. (2017). A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity. J Transl Med, 15(1), 201.Springer Nature. doi: 10.1186/s12967-017-1301-x.
  • Rai, P.K., Chodisetti, S.B., Nadeem, S., Maurya, S.K., Gowthaman, U., Zeng, W., Janmeja, A.K., Jackson, D.C., & Agrewala, J.N. (2016). A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host. Sci Rep, 6(1), 23917.Springer Nature. doi: 10.1038/srep23917.
  • Kujur, W., Gurram, R.K., Haleem, N., Maurya, S.K., & Agrewala, J.N. (2015). Caerulomycin A inhibits Th2 cell activity: a possible role in the management of asthma. Sci Rep, 5(1), 15396.Springer Nature. doi: 10.1038/srep15396.
  • Gurram, R.K., Kujur, W., Maurya, S.K., & Agrewala, J.N. (2014). Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs). J Biol Chem, 289(25), 17515-17528.Elsevier. doi: 10.1074/jbc.M113.545871.
  • Mushtaq, K., Chodisetti, S.B., Rai, P.K., Maurya, S.K., Amir, M., Sheikh, J.A., & Agrewala, J.N. (2014). Decision-making critical amino acids: role in designing peptide vaccines for eliciting Th1 and Th2 immune response. Amino Acids, 46(5), 1265-1274.Springer Nature. doi: 10.1007/s00726-014-1692-4.
  • Nair, R.G., & Kaur, G. Genome Mining and Comparative Genomic Analysis of Five Coagulase- Negative Staphylococci (CNS) Isolated from Human Colon and Gall Bladder. Journal of Data Mining in Genomics & Proteomics, 2016(02).OMICS International. doi: 10.4172/2153-0602.1000192.

  • Maurya, S.K., Tuan, G., Shetty, A., Gau, D., & Roy, P. (2026). Functional loss of actin-regulatory protein Profilin1 in vascular endothelial cells promotes a T-cell supportive chemical milieu in kidney cancer in a TRIM24-dependent manner. In CANCER RESEARCH, 86(5), (p. PR016).American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.KIDNEY26-PR016.